pharmaceutical

Consumers and insurers charged that Mylan, Pfizer and other companies engaged in an illegal scheme to monopolize the EpiPen market by hiking the device’s price from $100 to $600.

Health care spending is growing a lot faster than inflation and per-capita income. But it's not because we're getting tons more care. It's because prices rise so fast.

One of America's richest companies will pay nearly $30 million to the state of Kansas for allegedly overcharging Medicaid for pharmaceuticals. Also, some towns in the Midwest are offering free land or $15,000 no-strings-attached checks to attract new residents.

Kansas Attorney General Derek Schmidt says Centene kept Kansas in the dark about drug discounts and used other strategies to squeeze more profit out of the state's Medicaid program.

Emails between an auditing firm and Kansas show how quickly the state bent to the company’s wishes to keep information out of public view. Experts say this reflects a disturbing national trend.

Law professors who reviewed the redacted content for the Kansas News Service struggled to understand why the state would consider it legal to black out the information.

Kansas taxpayers and state employees could be paying too much for prescription drugs, but a state-commissioned report doesn't actually say if customers got a bargain or got gouged. Kansas even tried to black out large swaths of the audit, but it botched many of the redactions.

Taxpayers and state employees could be paying too much for medications. Experts say a 16-page audit commissioned by Kansas doesn't dig in to find out.

A state agency said its redactions shield trade secrets. But the text below the black remained readable. So we took it to experts in antitrust and public records law.

Being a middleman in the $1 trillion pharmaceutical industry is big business. The middlemen can even earn more than the drugmakers on prescription drugs.